Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant Tumor
Conclusions: The findings of this meta-analysis highlight the role of p62 as a useful prognostic biomarker for some types of tumor according to different clinicopathologic features, which may contribute to the selection of effective treatment methods for different malignant tumors.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Linhai Zhu, Yiqing Wang, Jing He, Jie Tang, Wang Lv, Jian Hu Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Liver | Science | Study | Urology & Nephrology